Associations between use of the 21-gene recurrence score assay and chemotherapy regimen selection in a statewide registry.

Henry, N Lynn

Associations between use of the 21-gene recurrence score assay and chemotherapy regimen selection in a statewide registry. [electronic resource] - Cancer 05 2017 - 948-956 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1097-0142

10.1002/cncr.30429 doi


Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Biomarkers, Tumor
Breast Neoplasms--diagnosis
Clinical Decision-Making
Female
Gene Expression Profiling--methods
Genetic Testing
Humans
Neoplasm Grading
Neoplasm Metastasis
Neoplasm Recurrence, Local--genetics
Neoplasm Staging
Prognosis
Registries